Skip to main content

Table 5 Distribution of resistance genes

From: Antimicrobial susceptibility and resistance mechanisms of methicillin resistant Staphylococcus aureusisolated from 12 Hospitals in Turkey

Number of Resistant isolates (%)

Antibiotics

Erythro*

Linco

Tetra

Genta

Cipro

Line

F. Acid

Vanco

Kana

225 (56.7)

168 (42.3)

350 (88.2)

358 (90.2)

366 (92.2)

0 (0)

32 (8.1)

0 (0)

363 (91.4)

Gene (%)

ermA (21.3)

ermA (5.4)

tetM (90)

aac-aph (93)

ND**

ND

ND

ND

ND

 

ermB (0)

ermB (0)

tetK (2.9)

      
 

ermC (8.9)

ermC (10.1)

       
 

ermA-B (0.4)

ermA-B (0.6)

       
 

ermB-C (0.4)

ermB-C (0.6)

       
 

ermA-C (56.9)

ermA-C (73.8)

       
 

ermA-B-C (0.9)

ermA-B-C ( 1.2)

       
 

msrA (0.9)

msrA (0)

       
 

msrA,ermA (0.9)

msrA,ermA (0)

       
 

msrA, ermB (0.4)

msrA, ermB (0)

       
 

msrA,ermC (0.4)

msrA,ermC (0.6)

       

linA, msrA (0.6)

msrA,ermA-C (1.8)

msrA,ermA-C (2.4)

       

Unknown (6.6)

Unknown (4.7)

Unknown (7.1)

Unknown (7)

     
  1. *Erythro, Erythromycin; Linco, Lincomycin; Tetra, Tetracycline; Genta, Gentamycin; Cipro, Ciprofloxacin; Line, Linezolid; F. Acid, Fusidic Acid; Vanco, Vancomycin; Kana, Kanamycin.
  2. **ND; Not Determined.